Catawba Research

Catawba Research is a full-service Global contract research organization (CRO) providing clinical management services to pharmaceutical, device, formulation development and biotechnology companies. With decades of pharmaceutical experience and talent, the company has established a sterling reputation in the industry, boasting a successful track record and a deep, broad network of professional partnerships and affiliations.

Founded in 2014 and headquartered in the United States, Catawba Research received a Venture Round investment at 07 October 2020 from St. Cloud Capital.

The company's executive leadership brings years of high-level clinical research experience, dedication and a lofty vision to the company. They, alongside the research associates and other team members, deliver talent, guidance, incredible work ethic, and, most importantly, superior service.

Catawba Research aims to offer comprehensive support for pharmaceutical product development processes, specializing in regulatory affairs, clinical operations, manufacturing, medical monitoring, and statistical services. The company emphasizes open communication, providing clients with suggestions, information, and expert advice when needed.

Overall, Catawba Research presents itself as a reliable and experienced partner for pharmaceutical and biotechnology companies seeking state-of-the-art clinical trial and data management services to bring their products to market.